DavideGSK Vaccines Siena

GSK in Italy and worldwideA science-ledglobal healthcarecompany with a special purpose.

A science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.We have 3 global businesses that discover, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.

Who we are

Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies.MariaScientific Investigator

Spain

GSK around the worldOur global scale

95,490employees aroundthe world

>150countries in whichwe operate

85%of employees are proud to work for GSK

6.9bnpacks/doses of medicines, vaccinesand healthcare products delivered in 2018

In Italy: where we are

Verona • GSK – Headquarters• ViiV - Headquarters• GSK Pharma Supply Chain - artworks

Baranzate • GSK Consumer Healthcare - Headquarters

Parma • GSK Pharma Supply Chain - manufacturing

Siena e Rosia • GSK Vaccines – R&D• GSK Vaccines – GIO&Q - manufacturing• GSK Vaccines - Headquarters• GSK Vaccines Institute for Global Health – R&D

In Italy: key facts

1,6 bn €overall turnover(dircet sales, licences, goods and services, export)

475 mln €generated export

193 mlnunits (medicines and vaccines) manufactured in Italy

373 mln €labour costs

More than a century of pharmaceutical tradition and innovation since 1904:

• In Siena since 1904• In Verona since 1932• In Parma since 1984• In Baranzate since 1992

What we do

We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people. StuartHIV patient

UK

In Italy: what we doPharmaceuticals Vaccines Consumer

Healthcare

52% of global 2019 turnover

21% 27%

50 GSK prescriptionmedicines in Italy.

Since 2009 ViiV Healthcare has been 100% dedicated to HIV, with 11 medicines in the Italian portfolio.

22 GSK vaccines in Italy, helping to protect people throughout their lives.

Over 20 brands,2 brands in the top10 OTC brands sold in Italy: Voltaren Emulgel 2% and Rinazina.

Ministry of Health Data 2018

Our Pharmaceuticals business has a broad portfolio of innovative and established medicines with leadership positions in respiratory and HIV. We are strengthening our pipeline through a focus on science related to the immune system, human genetics and advanced technologies.

Pharmaceuticals

52%of global turnover 2019

Worldwide

39 Rx products in our pipeline YE 2019

2,3 bn packs of medicines distributed

50 years in respiratory, from Ventolin launch in 1969

Vaccines

21%of global turnover 2019

We are the leading vaccines company in the world, delivering over 2 million vaccine doses every day to people living in over 150 countries. Our portfolio helps protect people throughout their lives. We have recently introduced breakthrough vaccines for meningitis B.

Worldwide

15 candidate vaccines in our pipeline

13 manufacturing sites dedicated to vaccines

2.500 vaccines researchers in US, Belgium and Italy

Consumer Healthcare

27%of global turnover 2019

We are the world’s largest Consumer Healthcare company following our new joint venture with Pfizer. We develop and market a portfolio of consumer-preferred and expert-recommended brands including Sensodyne, Parodontax, Voltaren.

Worldwide

36 new launches

3,8 bn packages of CH products distributed

Joint venture with Pfizer

How we do it

Everyone at GSK is focused on our 3long-term priorities:

InnovationPerformanceTrust

ArthurOncology ScientistUSA

We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.

In Italy, we are at the forefront in vaccines R&D, production and for delivering future HIV treatments.

InnovationOur long-term priorities

18Italian product launches expected in 2019-20:2 in respiratory,3 in HIV, 1 in oncology,9 Consumer Healthcare

30 mln €invested in Parma: a new facility producing a new HIV treatment to help people living with HIV

46clinical trials currently running in over 200 hospital centers

42 mln €invested in Rosia: new technologies, processes and a new vaccines facility to improve quality control

In 2018 we doubled the number of oncology projects in development through our own science, the acquisition of TESARO and other alliances.

16 oncology products are now in our global pipeline.

DaveScientis, oncologyStevenage

PerformanceWe drive growth and profitability by disciplined investment in our strategic priorities, attracting and developing great people and high quality execution.

Our commercial results and industrial investments contribute to the health and wellbeing of Italy, as well as to the local economy.

Our long-term priorities

1 in 4patients with chronic respiratory disease in Italy are treated with GSK products

31.000people living with HIV in Italy are treated with medicines from ViiV Healthcare

2GSK OTC brands among top 10 sold in Italy: Rinazina and Voltaren Emulgel 2%MOH Data November 2018

430.000new born babies in Italy are vaccinated with at least one GSK vaccine in first year of age

AlessandraGSK VaccinesRosia (SI)

In 2019, a new QualityControl facility openedin GSK vaccines site in Siena, thanks to a 42 mio € investment.Our men B vaccines wasdiscovered in Siena.Our men vaccines and glyco-conjugates are manufactured in Rosia.

TrustWe are a responsible company and commit to use our science and technology to address health needs, make our products affordable and available, and to be a modern employer.

Our long-term priorities

>40scientists dedicated to neglected diseases, such as shigella and typhoid fever, at GSK’s Vaccines Institute for Global Health in Siena

23.400contacts from citizens and patients managed via Consumer Service and Medical Information

96colleagues selected as volunteers at Dynamo Camp: our enterprise volunteership program

50%of GSK employees in Italy are women

A new headquarter in Verona in 2020: a 100% innovative and smart workspace, bringing back to life Building 25, a part of Verona historicalMagazzini Generali (wholesale market)

Our values and expectations are at the heart of everything we do and define our culture – so that together we can deliver extraordinary impact for patients and consumers and make GSK a brilliant place to work.

Our values and expectations

To help people do more, feel better, live longer.

Isaure and MaximillenBelgium

Why we do it

www.gsk.it

Materiale Istituzionale ad uso esterno - La presente comunicazione e le informazioni ivi contenute sono puramente informative dell’impegno, dell’attività e dei risultati di GSK nello sviluppare, studiare e mettere a disposizione dei pazienti nuove medicine e soluzioni terapeutiche. Non sostituisce in alcun modo la necessaria valutazione medica di una eventuale patologia del singolo e conseguente scelta terapeutica che deve essere effettuata solo dal medico curante. Non è intesa a promuovere la prescrizione, la fornitura, la vendita o il consumo di medicinali e dunque non è soggetta alle norme di cui al Titolo VIII – Pubblicità del D.Lgs. 219/06. Tutti i diritti sono riservati a GlaxoSmithKline S.p.A.I dati economici e di attività sono relativi all’anno 2018, salvo dove diversamente specificato. | Aggiornamento Febbario 2020

Twitter | Facebook | YouTube

www.gsk-salute.itfor healthcare professionals

Slide Number 1Slide Number 2Slide Number 3Slide Number 4Slide Number 5Slide Number 6Slide Number 7Slide Number 8Slide Number 9Slide Number 10Slide Number 11Slide Number 12Slide Number 13Slide Number 14Slide Number 15Slide Number 16Slide Number 17Slide Number 18Slide Number 19Slide Number 20Slide Number 21